References
- Qin YH, Zhou TB, Su LN, et al. Association between ACE polymorphism and risk of IgA nephropathy: A meta-analysis. J Renin Angiotensin Aldosterone Syst. 2011;12:215–223
- Rosenblad T, Rebetz J, Johansson M, et al. Eculizumab treatment for rescue of renal function in IgA nephropathy. Pediatr Nephrol. 2014;29:2225–2228
- Kiryluk K, Novak J. The genetics and immunobiology of IgA nephropathy. J Clin Invest. 2014;124:2325–2332
- Ko GJ, Lee EA, Jeon US, et al. The association of Klotho polymorphism with disease progression and mortality in IgA nephropathy. Kidney Blood Press Res. 2012;36:191–199
- Wang W, Sun Y, Fu Y, et al. Interaction of C1GALT1-IL5RA on the susceptibility to IgA nephropathy in Southern Han Chinese. J Hum Genet. 2013;58:40–46
- Zhou TB, Yin SS, Liang R. A meta-analysis of the association between angiotensin-converting enzyme insertion/deletion gene polymorphism and end-stage renal disease risk in IgA nephropathy patients. J Renin Angiotensin Aldosterone Syst. 2013;14:235–241
- Zhou XJ, Cheng FJ, Qi YY, et al. FCGR2B and FCRLB gene polymorphisms associated with IgA nephropathy. PLoS One. 2013;8:e61208
- Miura S, Karnik SS, Saku K. Review: Angiotensin II type 1 receptor blockers: Class effects versus molecular effects. J Renin Angiotensin Aldosterone Syst. 2011;12:1–7
- Zhou TB, Yin SS, Jiang ZP. Association of angiotensin II type-1 receptor A1166C gene polymorphism with the susceptibility of end-stage renal disease. J Recept Signal Transduct Res. 2013;33:325–331
- Wang JL, Li X, Hao PP, et al. Angiotensin II type 1 receptor gene A1166C polymorphism and essential hypertension in Chinese: A meta-analysis. J Renin Angiotensin Aldosterone Syst. 2010;11:127–135
- Zhou TB, Guo XF, Yin SS. Association of peroxisome proliferator-activated receptor gamma Pro12Ala gene polymorphism with type 2 diabetic nephropathy risk in Caucasian population. J Recept Signal Transduct Res. 2014;34:180–184
- Zhou TB, Guo XF, Yin SS. Association of T869, C509T, G915C gene polymorphism of transforming growth factor-beta1 with IgA nephropathy risk. Ren Fail. 2014;36:823–828
- Zhou TB, Jiang ZP, Qin YH, et al. Association of transforming growth factor-beta1 T869C gene polymorphism with diabetic nephropathy risk. Nephrology (Carlton). 2014;19:107–115
- Zhou TB, Drummen GP, Jiang ZP, et al. GSTT1 Polymorphism and the risk of developing prostate cancer. Am J Epidemiol. 2014;180:1–10
- Zhou TB, Jiang ZP. Association between plasminogen activator inhibitor-1 4G/5G gene polymorphism and immunoglobulin A nephropathy susceptibility. J Recept Signal Transduct Res. 2014; [Epub ahead of print]
- Zhou TB, Jiang ZP, Huang MF. Association of vitamin D receptor BsmI (rs1544410) gene polymorphism with the chronic kidney disease susceptibility. J Recept Signal Transduct Res. 2014; [Epub ahead of print]
- Pei Y, Scholey J, Thai K, et al. Association of angiotensinogen gene T235 variant with progression of immunoglobin A nephropathy in Caucasian patients. J Clin Invest. 1997;100(4):814–820
- Maruyama K, Yoshida M, Nishio H, et al. Polymorphisms of renin-angiotensin system genes in childhood IgA nephropathy. Pediatr Nephrol. 2001;16:350–355
- Woo KT, Lau YK, Choong LH, et al. Polymorphism of renin-angiotensin system genes in IgA nephropathy. Nephrology (Carlton). 2004;9:304–309
- Huang HD, Lin FJ, Li XJ, et al. Genetic polymorphisms of the renin-angiotensin-aldosterone system in Chinese patients with end-stage renal disease secondary to IgA nephropathy. Chin Med J (Engl). 2010;123:3238–3242